Evidence map›Paper›PMID 30023672›Full record

ArticleACS omega2017

Cytotoxic Spiroepoxide Lactone and Its Putative Biosynthetic Precursor from

Louise C Forster, Gregory K Pierens, Andrew M White, Karen L Cheney, Pradeep Dewapriya, Robert J Capon, Mary J Garson

Abstract read
In one paragraph

Article in ACS omega, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Louise C ForsterSchool of Chemistry and Molecular Biosciences, Centre for Advanced Imaging, School of Biological Sciences, and Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia.
Gregory K PierensSchool of Chemistry and Molecular Biosciences, Centre for Advanced Imaging, School of Biological Sciences, and Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia.
Andrew M WhiteSchool of Chemistry and Molecular Biosciences, Centre for Advanced Imaging, School of Biological Sciences, and Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia.
Karen L CheneySchool of Chemistry and Molecular Biosciences, Centre for Advanced Imaging, School of Biological Sciences, and Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia.
Pradeep DewapriyaSchool of Chemistry and Molecular Biosciences, Centre for Advanced Imaging, School of Biological Sciences, and Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia.
Robert J CaponSchool of Chemistry and Molecular Biosciences, Centre for Advanced Imaging, School of Biological Sciences, and Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia.
Mary J GarsonSchool of Chemistry and Molecular Biosciences, Centre for Advanced Imaging, School of Biological Sciences, and Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epoxygoniolide-1 (

Identifiers

PMID30023672
PMCPMC6044697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.